Andrew Berens

Andrew Berens

Analyst-Equity presso
Leerink Partners LLC
Finance
Consumer Services

Profilo

Dr. Andrew Berens is a Senior Managing Director at Leerink Partners LLC.
He is a Senior Research Analyst at Leerink Partners covering Targeted Oncology.
Prior to joining the firm in June 2018, Dr. Berens was an Executive Director and Senior Biotechnology Research Analyst at Morgan Stanley focusing on mid and small cap biotechnology companies.
Dr. Berens practiced as an Emergency Medicine Physician for a decade before starting his career in equity research.
He also worked in the pharma industry at Ikaria Pharmaceuticals, where he was a Senior Director in business development, leading search and development efforts.
Dr. Berens earned MBA degrees from Columbia Business School and London Business School, his M.D.
from Emory University and an undergraduate degree in English Literature from Tulane University.

Posizioni attive di Andrew Berens

SocietàPosizioneInizio
Analyst-Equity 01/06/2018

Precedenti posizioni note di Andrew Berens

SocietàPosizioneFine
Analyst-Equity 01/06/2018
Analyst-Equity 28/02/2015
Corporate Officer/Principal 30/04/2014
Analyst-Equity 31/03/2009
Analyst-Equity 30/03/2007
Vedi nel dettaglio l'esperienza di Andrew Berens

Formazione di Andrew Berens

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

95

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Finance

Finance

Finance

Finance

Finance

Finance

Consumer Services

Consumer Services

Consumer Services

  1. Mercati
  2. Insiders
  3. Andrew Berens